Ucb Sa Stock Five Year Return
| UCB Stock | EUR 139.05 0.50 0.36% |
UCB SA fundamentals help investors to digest information that contributes to UCB SA's financial success or failures. It also enables traders to predict the movement of UCB Stock. The fundamental analysis module provides a way to measure UCB SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to UCB SA stock.
UCB |
UCB SA Company Five Year Return Analysis
UCB SA's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current UCB SA Five Year Return | 1.63 % |
Most of UCB SA's fundamental indicators, such as Five Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UCB SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, UCB SA has a Five Year Return of 1.63%. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The five year return for all Belgium stocks is notably lower than that of the firm.
UCB Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses UCB SA's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of UCB SA could also be used in its relative valuation, which is a method of valuing UCB SA by comparing valuation metrics of similar companies.UCB SA is currently under evaluation in five year return category among its peers.
UCB Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0468 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 15.81 B | |||
| Shares Outstanding | 189.96 M | |||
| Shares Owned By Insiders | 38.03 % | |||
| Shares Owned By Institutions | 40.78 % | |||
| Price To Earning | 17.19 X | |||
| Price To Book | 1.55 X | |||
| Price To Sales | 2.39 X | |||
| Revenue | 5.78 B | |||
| Gross Profit | 4.34 B | |||
| EBITDA | 1.6 B | |||
| Net Income | 1.06 B | |||
| Cash And Equivalents | 1.28 B | |||
| Cash Per Share | 6.77 X | |||
| Total Debt | 1.97 B | |||
| Debt To Equity | 23.90 % | |||
| Current Ratio | 1.32 X | |||
| Book Value Per Share | 46.94 X | |||
| Cash Flow From Operations | 1.55 B | |||
| Earnings Per Share | 4.57 X | |||
| Price To Earnings To Growth | 6.29 X | |||
| Target Price | 100.8 | |||
| Number Of Employees | 8.6 K | |||
| Beta | 0.34 | |||
| Market Capitalization | 14.84 B | |||
| Total Asset | 14.21 B | |||
| Retained Earnings | 2.92 B | |||
| Working Capital | (223 M) | |||
| Current Asset | 2.84 B | |||
| Current Liabilities | 3.06 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.63 % | |||
| Net Asset | 14.21 B | |||
| Last Dividend Paid | 1.3 |
About UCB SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze UCB SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UCB SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UCB SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for UCB Stock Analysis
When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.